We are live on
!
Find out more
RC
Roundview Capital Portfolio holdings
AUM
$1.83B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+8.47%
1 Year Est. Return
+26.02%
3 Year Est. Return
+77.66%
5 Year Est. Return
+94.56%
10 Year Est. Return
+341.66%
AUM
$1B
AUM Growth
+$95.5M
(+11%)
Cap. Flow
+$28.2M
Cap. Flow
% of AUM
2.81%
Top 10 Holdings %
Top 10 Hldgs %
30.49%
Holding
309
New
24
Increased
150
Reduced
79
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$2.16M |
| 2 |
CBIZ
CBZ
|
+$2.09M |
| 3 |
Boston Omaha
BOC
|
+$1.92M |
| 4 |
Alibaba
BABA
|
+$1.8M |
| 5 |
Brown-Forman Class B
BF.B
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$1.69M |
| 2 |
Stanley Black & Decker
SWK
|
+$1.1M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$1.03M |
| 4 |
Zimmer Biomet
ZBH
|
+$981K |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$953K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14% |
| 2 | Financials | 12.34% |
| 3 | Communication Services | 8.26% |
| 4 | Healthcare | 7.99% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Cigna
CI
$76.1B
| $848K | 0.08% |
3,695
| – | – |
|
202
Travelers Companies
TRV
$78.4B
| $848K | 0.08% |
5,421
+10
| +0.2% | +$1.56K |
|
203
Elevance Health
ELV
$81.6B
| $837K | 0.08% |
1,806
-131
| -7% | -$55.1K |
|
204
Intercontinental Exchange
ICE
$88.4B
| $831K | 0.08% |
6,079
+1
| +0% | +$132 |
|
205
AutoZone
AZO
$49.1B
| $826K | 0.08% |
+394
| New | +$734K |
|
|
RDS.A
206
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $814K | 0.08% |
18,747
-60
| -0.3% | -$2.71K |
|
207
Illumina
ILMN
$31B
| $805K | 0.08% |
2,176
-26
| -1% | -$9.85K |
|
|
ENV
208
DELISTED
ENVESTNET, INC.
ENV
| $786K | 0.08% |
+9,910
| New | +$807K |
|
209
Chubb
CB
$135B
| $785K | 0.08% |
4,059
| – | – |
|
210
United Therapeutics
UTHR
$26.2B
| $781K | 0.08% |
3,614
+2,035
| +129% | +$399K |
|
|
PSTH
211
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $779K | 0.08% |
39,497
-11,748
| -23% | -$233K |
|
212
Deere & Co
DE
$162B
| $774K | 0.08% |
2,257
+256
| +13% | +$89.1K |
|
213
Idexx Laboratories
IDXX
$44.1B
| $774K | 0.08% |
+1,175
| New | +$738K |
|
214
Novartis
NVS
$301B
| $773K | 0.08% |
8,839
-897
| -9% | -$74.5K |
|
215
Globus Medical
GMED
$10.9B
| $761K | 0.08% |
10,540
| – | – |
|
216
Domino's
DPZ
$11.7B
| $760K | 0.08% |
1,346
+34
| +3% | +$17.3K |
|
217
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.3B
| $738K | 0.07% |
18,700
| – | – |
|
218
Fair Isaac
FICO
$26.4B
| $737K | 0.07% |
+1,700
| New | +$675K |
|
|
ATVI
219
DELISTED
Activision Blizzard
ATVI
| $721K | 0.07% |
10,841
-5,030
| -32% | -$344K |
|
220
ExxonMobil
XOM
$651B
| $678K | 0.07% |
11,079
-1,441
| -12% | -$90.1K |
|
221
ASML
ASML
$634B
| $665K | 0.07% |
835
+384
| +85% | +$305K |
|
222
Vanguard Dividend Appreciation ETF
VIG
$112B
| $648K | 0.06% |
3,774
-47
| -1% | -$7.75K |
|
223
Spotify
SPOT
$107B
| $644K | 0.06% |
2,750
-895
| -25% | -$224K |
|
224
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $638K | 0.06% |
7,338
+3
| +0% | +$260 |
|
225
Starbucks
SBUX
$121B
| $608K | 0.06% |
5,200
+614
| +13% | +$69.2K |
|
Similar funds
SI
WIC
DE
KAM
OQS
RP
DWT
ABTD
Roundview Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Roundview Capital held 309 positions worth $1B, up 11% from $907M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Roundview Capital's Q4 2021 filing shows 24 new, 150 increased, 79 reduced and 13 closed positions. Its largest new stake was CBIZ: 56,105 shares worth $2.19M. The largest sale was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $1.69M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
- Roundview Capital's largest Q4 2021 buy was CBIZ: 56,105 shares worth $2.19M.
- Roundview Capital added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2021, an estimated $2.16M increase.
- Roundview Capital's biggest Q4 2021 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $1.69M.
- Roundview Capital fully exited Zimmer Biomet in Q4 2021, selling an estimated $981K.
- Roundview Capital's ten largest holdings make up 30% of its $1B portfolio in Q4 2021.
- Roundview Capital opened 24 new positions and closed 13 in Q4 2021.
- Roundview Capital's portfolio value rose 11% quarter-over-quarter to $1B.
Based on Roundview Capital's 13F filing for Q4 2021, filed 10 Feb 2022.